The growth of this market is fueled by increased R&D investments and research grants; advances in technology and innovative rotor designs; a rising prevalence of infectious diseases leading to more sample testing; an expanding research pipeline for cell-based and OMICS research; and the integration of automation and advanced features in laboratory centrifuges. Additionally, epidemic outbreaks and greater awareness of infectious diseases increase demand for reliable lab testing and sample processing, directly boosting centrifuge sales.
Equipment as a product segment will lead the market in 2025.
Based on product, the laboratory centrifuges market is segmented into equipment and accessories. In 2025, the equipment segment held the largest share of the laboratory centrifuges market. The significant share of the equipment segment can be attributed to the need for repeated purchases of accessories such as tubes, bottles, and buckets. Demand for laboratory centrifuge equipment remains strong due to ongoing technological advancements and continuous upgrades and replacement cycles in research and clinical laboratories. As new centrifuge platforms with improved features (such as higher speeds, digital interfaces, and automation capabilities) become available, organizations are driven to upgrade older equipment, further fueling growth in this segment.Benchtop centrifuges hold the largest share of the laboratory centrifuges market in 2025.
Based on platform type, the laboratory centrifuges market is segmented into benchtop and floor-standing centrifuges. Among these, the benchtop centrifuges segment holds the largest market share because these centrifuges are affordable, versatile, easy to operate, compact, and lighter in weight. Their simplicity in operation and maintenance increases their popularity, especially for laboratories with smaller teams or limited technical resources.Versatility is another key benefit; benchtop centrifuges are capable of handling a wide variety of sample types and volumes, making them suitable for different protocols in diagnostics, biochemistry, microbiology, and molecular biology. Their cost-effectiveness compared to larger floor-standing models makes benchtop centrifuges accessible to budget-constrained institutions, promoting widespread use in both established and emerging markets. These benefits have led to their growing adoption in the laboratory centrifuges market.
The hospitals segment held the largest share of the laboratory centrifuges market in 2025.
The hospitals segment holds the largest share of the laboratory centrifuges market due to several interconnected trends and needs within the healthcare industry. Hospitals are on the frontline for diagnosis, disease monitoring, and treatment, which require extensive laboratory testing, most of which depend on centrifugation for activities such as blood separation, plasma analysis, and preparation of samples for microbiology or molecular diagnostics.The increase in the prevalence of chronic and infectious diseases has boosted diagnostic workloads, prompting hospitals to invest in more centrifuges and advanced, automated platforms that can process samples quickly and reliably. Additionally, the rapid growth of healthcare infrastructure, particularly in emerging economies - alongside rising healthcare spending and government initiatives to enhance diagnostic capacity - are expanding the number of hospitals and, consequently, increasing demand for centrifuge equipment. Collectively, these trends ensure that hospitals remain the primary end user in the laboratory centrifuges market and continue to drive the highest volume of purchases and innovation in this sector.
The Asia Pacific regional segment is expected to register the highest CAGR in the laboratory centrifuges market during the forecast period.
The Asia Pacific region is experiencing the fastest growth rate in the global laboratory centrifuges market during the forecast period. One of the main factors is the rapid economic development of emerging economies like China and India, which are significantly increasing their investments in healthcare infrastructure, scientific research, and laboratory capabilities.The rise in healthcare spending and government initiatives to enhance healthcare access and diagnostic services are driving market growth for laboratory equipment in this region. Another key aspect is the surge in R&D investments by pharmaceutical and biotechnology companies, which are increasingly establishing research and manufacturing hubs in countries like China, India, and other Southeast Asian nations. This trend is supported by the growing number of hospitals, diagnostic centers, and academic institutions, creating strong demand for advanced laboratory instruments - including centrifuges.
A breakdown of the primary participants referred to for this report is provided below:
- By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
Research Coverage
- The report studies the laboratory centrifuges market based on product, platform type, rotor design, application, end user, and region.
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micromarkets with respect to their growth trends, prospects, and contributions to the global laboratory centrifuges market.
- The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying this Report
This report is valuable for both new and existing market players, providing essential information to spot potential investment opportunities. It offers a comprehensive overview of major and minor competitors, supporting effective risk assessment and informed investment choices. The report features precise segmentation based on end users and geographic regions, giving detailed insights into niche market segments. Additionally, it highlights key trends, drivers of growth, challenges, and opportunities, aiding strategic decision-making through balanced analysis.Through this report, readers get insightful views into the following parameters:
- Analysis of key drivers: The rising prevalence of acute and chronic diseases increases the demand for advanced diagnostic testing and sample processing in clinical, research, and pharmaceutical labs. Integration of smart features (IoT, automation, digital interfaces), improved rotor design, higher throughput, and energy-efficient systems are boosting performance and user convenience. These technological advancements will propel the market growth.
- Product development/innovation: Launch of next-generation benchtop and micro-centrifuges with smart safety features, energy efficiency, and enhanced rotor selection (Eppendorf 5427 R, Kubota S500T); focus on user-friendly interfaces, remote diagnostics, and compliance with green standards; increase in development of single-use consumables, customizable rotor systems, and improvements in temperature-controlled/refrigerated platforms to meet specialized research needs.
- Market development: Strong demand from hospitals, biotech firms, research institutes, and environmental/food testing laboratories
- Market diversification: Expansion into new applications, including cellomics, microbiological culture, and point-of-care diagnostics, supported by modular and portable centrifuge offerings
- Competitive assessment: Comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), KUBOTA Corporation (Japan, Sigma Laborzentrifugen GmbH (Germany, Andreas Hettich GmbH & Co. KG (Germany), NuAire (US), QIAGEN N.V. (Netherlands), Sartorius AG (Germany), HERMLE Labortechnik GmbH (Germany), Cardinal Health (US), and Centurion Scientific (UK)
Table of Contents
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Danaher
- Eppendorf
- Qiagen N.V.
- Sartorius AG
- Sigma Laborzentrifugen GmbH
- Mettler Taledo Group (Hermle)
- Bio-Rad
- Agilent Technologies, Inc.
- Andreas Hettich GmbH & Co.KG
- Centurion Scientific
- Haier Biomedical
- Heal Force Bio-Meditech Holdings
- Benchmark Scientific
- Laby Instruments Industry
- Kay & Company
- Narang Medical Limited
- Remi Group
- Vision Scientific Co. Ltd.
- Corning
- Nuaire
- Kubota Corporation
- Antylia Scientific (Cole-Parmer India Pvt. Ltd.)
- Madison Industries
- Boekel Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 258 |
| Published | November 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 1.58 Billion |
| Forecasted Market Value ( USD | $ 1.86 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |


